Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section wording updated to state that publications are automatically filled from PubMed. The page revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe funding-status notice was removed, but the core trial details (overview, eligibility, and locations) remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check34 days agoChange DetectedThe screenshot shows minor UI and layout adjustments on the Study Details page, with no changes to the study data, eligibility criteria, or listed locations (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.3%

- Check63 days agoChange DetectedUpdated page to version v3.2.0, added operating-status notice and a new resource on Spinal muscular atrophy; removed the old revision v3.1.0 reference.SummaryDifference2%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page updates the revision from v3.0.1 to v3.0.2 and removes the Back to Top element. This does not affect core content or other critical information.SummaryDifference0.1%

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.